Apellis Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
76.38
|
|
Average Rating
|
4.29
|
|
# Strong Buys
|
9
|
|
# Buys
|
4
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.45
|
-1.75
|
-0.30
|
-20.69%
|
|
2022-06-30
|
-1.36
|
-1.46
|
-0.10
|
-7.35%
|
|
2022-03-31
|
-1.32
|
-1.42
|
-0.10
|
-7.58%
|
|
2021-12-31
|
-1.54
|
-1.61
|
-0.07
|
-4.55%
|
|
2021-09-30
|
-1.70
|
-2.28
|
-0.58
|
-34.12%
|
|
2021-06-30
|
-1.69
|
-2.72
|
-1.03
|
-60.95%
|
|
2021-03-31
|
-1.62
|
-2.32
|
-0.70
|
-43.21%
|
|
2020-12-31
|
-0.75
|
0.93
|
1.68
|
224.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.63
|
|
2021-12-31
|
-8.93
|
|
2020-12-31
|
-4.72
|
|
2019-12-31
|
-4.86
|
|
2018-12-31
|
-2.33
|
|
2017-12-31
|
-4.30
|